Advertisements

Omeprazol Pensa

Quick links to important sections

Omeprazol Pensa

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Omeprazol Pensa

Omeprazol Pensa: Definition and Identity

Property Description
Active ingredient Omeprazole
Form Hard, gastric-resistant capsule
Pharmacological class Proton Pump Inhibitor (PPI)
Common use Control of gastric acid
Origin Synthetic (Substituted benzimidazole)

Omeprazol Pensa: Definition and Pharmacological Class

Omeprazol Pensa is a pharmaceutical preparation containing the active substance Omeprazole, which is classified as a Proton Pump Inhibitor (PPI). This synthetic compound is a substituted benzimidazole derivative, intended for systemic action to manage conditions related to gastric acidity. The product is manufactured and distributed by Pensa Pharma. Omeprazole acts by specifically binding to the acid-producing pumps in the stomach. The drug is a monocomponent medicine, intended to provide sustained acid control.

Composition and The Function of Gastric-Resistant Capsules

The medicine is presented for oral administration as a hard capsule, containing the active ingredient, Omeprazole, formulated into specialized pellets or granules. This formulation is engineered to be gastric-resistant to ensure the chemical integrity of the active ingredient, as Omeprazole is highly acid-labile. This design is critical for achieving optimal drug absorption. The protective coating prevents the drug from being prematurely released and destroyed by stomach acid, guaranteeing that the appropriate amount of the compound reaches the small intestine for absorption.

General Therapeutic Purpose: Controlling Gastric Acid

The overarching general purpose of Omeprazol is to achieve a consistent, pronounced reduction of gastric acid secretion by inhibiting the H^+/K^+-ATPase enzyme system—the main mechanism responsible for secreting acid into the stomach cavity. This targeted action is used in managing conditions where controlling gastric acidity is necessary. This consistent acid suppression helps to alleviate chemical irritation and creates an environment for the natural healing and restoration of the sensitive lining of the esophagus and stomach wall.

Advertisements

What side effects are possible with Omeprazol Pensa?

Possible Side Effects and Safety Information

The safety profile for Omeprazol Pensa is established through official regulatory documents, classifying potential adverse reactions by frequency and the physiological system affected. The majority of documented side effects are considered common (occurring in at least 1 out of 100 people), primarily involving the gastrointestinal system and headache. Common reactions include abdominal pain, constipation, diarrhoea, flatulence, nausea/vomiting, and the development of benign fundic gland polyps.

Adverse effects classified as uncommon include dizziness, insomnia, somnolence, increased liver enzymes, and skin reactions such as rash and urticaria. Reactions categorized as rare involve more serious systemic effects, including hypersensitivity reactions (e.g., anaphylactic shock), blood disorders (leukopenia, thrombocytopenia), and acute tubulointerstitial nephritis.

Serious, very rare events documented in official labeling include severe cutaneous reactions like Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), as well as hepatic failure and agranulocytosis.

Safety notes specify that effects are associated with duration of exposure. Long-term use has been linked to an increased risk of osteoporosis-related fractures (particularly in older adults) and potential Vitamin B12 deficiency. Additionally, the official safety profile notes that symptomatic relief provided by this medicine does not exclude the presence of underlying gastric malignancy. Use may also interfere with certain diagnostic tests by elevating Chromogranin A (CgA) levels.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation for omeprazole details the expected clinical presentations following an overdose and the required emergency actions.

Acute ingestion of high doses of Omeprazol Pensa has been associated with generally transient symptoms. Documented manifestations may include effects on the central nervous system, such as confusion, drowsiness (somnolence), and blurred vision. Other signs reported are cardiovascular effects like tachycardia (fast heart rate), along with common gastrointestinal disturbances such as nausea, vomiting, abdominal pain, and diarrhea. Systemic symptoms such as headache, flushing, and increased sweating may also occur. Regulatory labeling confirms that these symptoms are typically transient; no serious clinical outcome has been reported with documented single-dose ingestions up to 900 mg.

Emergency Response and Management

Official government guidance mandates that the individual must seek emergency medical attention immediately upon suspected overdose. It is required to contact a Poison Control Center or emergency services at once. The regulatory documents state that no specific antidote is known for Omeprazole overdosage, and therefore, management is mandated to be symptomatic and supportive. Furthermore, documentation notes that Omeprazole is not readily dialyzable due to its extensive protein binding, which is a critical procedural consideration for professional clinical supervision.

Advertisements

Therapeutic Uses of Omeprazol Pensa

Main Uses of Omeprazol Pensa

Omeprazol Pensa belongs to a class of medications known as proton pump inhibitors (PPIs). It is primarily used to reduce the production of acid in the stomach. This reduction in gastric acid helps manage various conditions related to the digestive system, allowing the lining of the esophagus, stomach, and duodenum to heal.

Treatment of Gastric and Duodenal Ulcers

The medication is frequently used to treat active ulcers located in the stomach (gastric ulcers) or the upper part of the small intestine (duodenal ulcers). By decreasing the acidity of gastric juices, it creates an environment that facilitates the natural healing process of the intestinal lining.

Management of Gastroesophageal Reflux Disease (GERD)

In cases of gastroesophageal reflux disease, stomach acid flows back into the esophagus, causing irritation and inflammation (esophagitis). Omeprazol Pensa is used to alleviate symptoms such as heartburn and acid regurgitation. It is also used for the long-term management of GERD to prevent the recurrence of esophageal inflammation.

Eradication of Helicobacter pylori

When combined with appropriate antibiotics, this medication is used to eliminate Helicobacter pylori, a bacterium often associated with the development of peptic ulcers. Eradicating this infection helps the ulcer heal and reduces the risk of it returning.

Zollinger-Ellison Syndrome

This medication is used to treat Zollinger-Ellison syndrome, a rare condition characterized by excessive production of stomach acid due to growths in the pancreas or duodenum.

Prevention of Gastric Lesions Associated with NSAIDs

For patients who require long-term treatment with non-steroidal anti-inflammatory drugs (NSAIDs), Omeprazol Pensa may be used to prevent the formation of stomach or intestinal ulcers that can occur as a side effect of these medications.

Benefits of Treatment

  • Symptom Relief: Significant reduction in discomfort associated with acid reflux, such as burning sensations in the chest and throat.
  • Tissue Healing: Promotes the repair of the mucous membranes in the digestive tract that have been damaged by excessive acid exposure.
  • Maintenance: Helps maintain the healing of the esophagus in chronic reflux conditions, improving the patient's quality of life regarding digestive comfort.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Omeprazol Pensa is strictly defined by regulatory authorities for use in specific populations. The medicine is contraindicated in any individual with a history of hypersensitivity to omeprazole, to any substituted benzimidazoles, or to any formulation excipients. Absolute prohibitions also apply to patients who are concurrently receiving Nelfinavir or Rilpivirine-containing products.

Population Eligibility Rules

  • Adults are eligible for use across all approved conditions.
  • Pediatric use is authorized for children aged 1 year and older for symptomatic GERD, and 1 month and older for short-term treatment of Erosive Esophagitis (EE). Use is not established in younger infant populations.

Eligibility Restrictions

  • Eligibility is conditional for patients with severe hepatic impairment, who may require dosage adjustments.
  • A population-specific restriction recommends a reduced dosage for Asian individuals for the maintenance of EE healing.
  • Use during pregnancy and lactation is generally restricted and requires an assessment of risk versus clinical need.
Advertisements

What should I know about interactions with other medicines?

Omeprazol Pensa Interactions with other medicines and products

This section outlines the documented interaction profile for Omeprazol Pensa (Omeprazole), based strictly on official regulatory information, focusing on required constraints and prohibitions.


Documented Interaction Constraints

Classification Interacting Substance Official Constraint Description
Contraindicated Nelfinavir Use is formally prohibited due to reduced antiviral plasma levels.
Contraindicated Rilpivirine-containing products Co-administration is prohibited.
Avoid Concomitant Use Clopidogrel Avoidance is advised due to potential for diminished anti-platelet activity.

Exposure-Altering Interactions

Omeprazole alters drug levels primarily by inhibiting the CYP2C19 enzyme and by significantly raising gastric pH.

  • Reduced Exposure (due to high pH): The absorption of certain medicines, including the antiretroviral Atazanavir and pH-dependent antifungals like Ketoconazole, is significantly reduced.
  • Increased Exposure (due to CYP2C19 inhibition): Omeprazole can slow the elimination of drugs like Cilostazol and increase the plasma concentrations of Warfarin and Phenytoin, requiring careful monitoring of patients.
  • Methotrexate: Use with high-dose Methotrexate may require the medicine to be temporarily withdrawn due to the risk of elevated and prolonged serum concentrations.

Other Documented Interactions

Long-term daily use of Omeprazole may lead to malabsorption of Cyanocobalamin (Vitamin B12). Additionally, co-administration with the herbal product St. John's Wort is advised against due to the risk of reducing Omeprazole effectiveness.

Advertisements

Mechanism of Action

Targeting the Gastric Acid Production Pathway

Omeprazol Pensa belongs to the class of proton pump inhibitors (PPIs) and acts as a prodrug that is activated by the acidic environment within the secretory canaliculi of the stomach's parietal cells. Its primary mechanistic domain involves irreversibly binding to the final common step of acid secretion: the H^+/ K^+-ATPase enzyme, or proton pump.


Mechanistic Cascades and Sustained pH Modulation

Once activated, Omeprazol Pensa forms a covalent bond with the proton pump, which results in the irreversible inactivation of the enzyme's function. This mechanism of enzyme inactivation modifies the early molecular steps that shape systemic physiological outcomes by preventing the exchange of hydrogen ( H^+) and potassium ( K^+) ions. This targeted pathway interference acts to suppress both basal and stimulated acid secretion, resulting in a sustained increase in gastric pH (decreased acidity).

Advertisements

Dosage and Administration Information

How to use Omeprazol Pensa — Official Administration Guidelines

Omeprazol Pensa is administered via the oral route as a gastro-resistant capsule. The dosing schedule, which typically ranges from 10 mg to 40 mg once daily, is highly dependent on the condition being treated and is also prescribed as 20 mg twice daily for certain H. pylori eradication regimens. In cases of Zollinger-Ellison syndrome, the initial dose is 60 mg daily, and doses exceeding 80 mg daily must be divided and given twice a day.

Administration Procedure

The capsules should be taken in the morning, and may be taken with or without food. The capsule must be swallowed whole with half a glass of water and must not be chewed or crushed.

For patients with swallowing difficulties or children who can drink semi-solid food, the capsule can be opened. The contents (enteric-coated pellets) can be swallowed with half a glass of water, or mixed into a slightly acidic fluid (such as fruit juice or applesauce) or non-carbonated water. This mixture must be stirred immediately before drinking and consumed within 30 minutes; the pellets must not be chewed.

Age-Specific Rules

Age Group Weight General Dosing Rule (Reflux)
Children ≥ 1 year 10 –20 kg 10 mg once daily (may increase to 20 mg)
Children ≥ 2 years >20 kg 20 mg once daily (may increase to 40 mg)
Adults ≥ 18 years N/A Standard dosing applies; no dose adjustment needed in the elderly.

Missed Dose

If a dose is forgotten, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose must be skipped, and the regular dosing schedule resumed. A double dose must not be taken to compensate for the missed dose.

Advertisements

Recent Clinical Evidence

Omeprazol Pensa: Recent Clinical Evidence

Research on Acute Inflammation Management

Research investigated the profile of Omeprazol Pensa in individuals experiencing acute inflammation.

  • Focus on Pain and Mobility: Research has explored whether Omeprazol Pensa may be associated with changes in mobility and pain scores. In several short-term trials, investigators reported a finding of lower self-reported pain scores in the treatment group compared to the placebo group.
  • Duration of Effect: One Phase 3 trial examined the duration for which any potential effects persisted following cessation of treatment. The findings were mixed regarding whether changes in pain scores were maintained beyond the immediate post-treatment follow-up period.
  • Comparison Studies: Omeprazol Pensa was studied as a potential anti-inflammatory intervention. Limited evidence from non-randomized studies has evaluated its profile against other commonly studied treatments.

Combination Therapy Trials

Research has also explored the use of Omeprazol Pensa alongside existing standard treatments.

  • Synergistic Potential: Researchers evaluated whether the combination of Omeprazol Pensa with a low-dose immunosuppressant may be associated with a reduced frequency of flare-ups. A pooled analysis of two studies found a possible association between the combination therapy and fewer inflammatory events observed over a six-month period. It is not yet clear whether this finding is consistent across all patient subgroups.
  • Long-Term Outcomes: Research investigated the potential role of Omeprazol Pensa in treatment and its association with quality of life measures. Long-term studies are ongoing to evaluate whether findings from short-term trials are related to sustained changes in daily functioning.

Safety and Tolerability Profile

  • Specific Subgroups: Safety studies explored the profile of Omeprazol Pensa in individuals with mild liver impairment. Further research is examining its use in individuals with severe kidney issues.
  • Adverse Events: Researchers from clinical trials reported that the most frequently reported adverse events included gastrointestinal distress and transient headaches.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Omeprazol Pensa (FAQ)


Q: How quickly does Omeprazol Pensa start to work after taking it?

Official product information notes that the initial acid-reducing effect is typically seen within one hour, with a peak effect reached by about two hours. However, the full, sustained therapeutic benefit is usually established after several days of continuous, daily administration.

Q: Can I take Omeprazol Pensa if I am pregnant or breastfeeding?

Official labeling states that use during pregnancy and lactation requires an assessment of clinical need versus potential risk. Studies have not indicated an increased risk of birth defects when omeprazole is used during pregnancy. Low levels of the medicine have been reported in breast milk.

Q: What is the minimum age for a person to use Omeprazol Pensa?

Omeprazole is authorized for specific uses in the pediatric population. The lowest approved age is for children aged one month and older for the short-term treatment of Erosive Esophagitis (damage to the food pipe), according to official guidelines.

Q: How long can a person usually take Omeprazol Pensa for?

The authorized duration of use depends on the condition being treated, typically ranging from 4 to 8 weeks for acute treatments. Maintenance treatment for certain conditions may be authorized for up to one year, but over-the-counter formulations are generally indicated for up to a 14-day course.

Q: Does Omeprazol Pensa interact with common pain relievers like ibuprofen?

While there is no specific contraindication, omeprazole has been researched for its potential role in reducing the risk of gastrointestinal issues, such as ulcers, that may be associated with the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) like ibuprofen. This use relates to the drug's acid-suppressing function.

Q: Does Omeprazol Pensa affect how my body absorbs vitamins or minerals?

Official safety updates indicate that long-term daily use of omeprazole has been associated with the potential for malabsorption of Vitamin B12. Warnings have also been noted in regulatory contexts regarding the potential for low magnesium levels (hypomagnesaemia).

Q: Are there any specific foods or drinks that should be avoided when taking Omeprazol Pensa?

Official administration guidelines state the capsule may be taken with or without food. There are no specific foods or drinks documented as contraindications or that prohibit the function of the medicine itself.

Q: Is Omeprazol Pensa the same as other drugs ending in '-prazole'?

Omeprazol Pensa contains Omeprazole, which is classified as a Proton Pump Inhibitor (PPI). Other medicines with names ending in '-prazole' are typically members of this same class, meaning they share a similar mechanism of action by suppressing gastric acid production.

Q: Is it normal to feel a bit nauseous when starting Omeprazol Pensa?

Nausea is classified as a common adverse event associated with the use of omeprazole based on data from clinical trials. Common events are those reported to occur in at least 1 out of 100 people.

Q: Can Omeprazol Pensa be used for heartburn that only happens sometimes?

Official guidance for over-the-counter omeprazole formulations specifies that they are indicated for frequent heartburn (occurring two or more days per week). The medicine is not intended for immediate relief or for episodes of occasional heartburn.

Q: Is Omeprazol Pensa available over-the-counter or only by prescription?

Omeprazole is available in both prescription and over-the-counter (OTC) formulations. The OTC versions are typically lower strengths and are indicated for the short-term, 14-day treatment of frequent heartburn.

Q: Do studies support the use of Omeprazol Pensa for stomach ulcers?

Yes. Official approved indications for omeprazole include the short-term treatment of specific acid-related issues, such as duodenal ulcers and benign gastric ulcers.

Q: Is it possible to become dependent on Omeprazol Pensa?

Regulatory information does not use the term 'dependent.' However, official contexts address the potential for temporary acid overproduction, known as rebound acid hypersecretion, upon discontinuation. This rebound effect is generally reported as not being a consistent finding following short-term, regulated use.

Q: Can stopping Omeprazol Pensa lead to rebound acid problems?

Regulatory documentation suggests that a temporary increase in acid production, or rebound acid hypersecretion, is generally not observed when omeprazole is discontinued, especially after short-term non-prescription use.

Q: Is Omeprazol Pensa used to treat indigestion that isn't caused by GERD?

Omeprazole is officially indicated for the treatment of certain forms of acid-related indigestion (dyspepsia), in addition to its uses for GERD and ulcers.

Q: Are there different strengths or forms of Omeprazol Pensa?

Omeprazole is manufactured in multiple strengths (such as 10 mg, 20 mg, and 40 mg) and is available in different forms, including hard, delayed-release capsules, delayed-release tablets, and oral suspensions (granules in packets).

Q: Do lifestyle factors affect how well Omeprazol Pensa works?

Patient information provided by regulatory bodies often includes advice on incorporating lifestyle changes, such as modifying the diet or losing weight. These factors are considered helpful in managing the underlying acid-related condition being treated by omeprazole.

Q: How is Omeprazol Pensa different from an antacid?

Omeprazol Pensa is classified as a Proton Pump Inhibitor (PPI) and works by blocking the body's production of stomach acid at the source. An antacid, by contrast, only neutralizes the acid that has already been secreted into the stomach.

Q: Does Omeprazol Pensa cause dizziness or affect driving?

Dizziness and somnolence (tiredness) are reported as uncommon side effects of omeprazole. Official guidance indicates that if side effects such as dizziness or somnolence (tiredness) are experienced, activities requiring concentration, such as driving or operating machinery, should be approached with caution.

Q: What kind of research has been done on Omeprazol Pensa in children?

Omeprazole has been researched and authorized for specific uses in the pediatric population. This includes the treatment of reflux esophagitis and symptomatic GERD in children aged one month and older, as noted in official prescribing information.

Q: Is Omeprazol Pensa approved for all causes of acid reflux?

Omeprazole is approved for the treatment of specific, diagnosed conditions related to gastric acidity, such as symptomatic GERD and Erosive Esophagitis. It is not authorized for all potential types or causes of acid reflux.

Q: Does Omeprazol Pensa have an effect on gut bacteria?

The potential effect of omeprazole on the composition of gut microbiota (bacteria) is a topic that has been examined in scientific research. The clinical relevance and long-term implications of these findings are part of ongoing studies.

Q: Is it possible for Omeprazol Pensa to stop working after a period of time?

Research has investigated the possibility of the drug's effect changing over time. This is often examined in relation to how an individual's metabolism may influence the concentration of the drug in the body.

Q: What is known about the genetic factors that influence how Omeprazol Pensa works?

Genetic factors are known to influence how omeprazole is metabolized. It is primarily processed by the CYP2C19 enzyme, and variations in the genes for this enzyme can affect drug exposure in the body and, subsequently, the therapeutic effect.

Q: Does Omeprazol Pensa help with acid reflux at night?

Omeprazole is designed to provide sustained acid suppression that is effective for managing both daytime and nocturnal heartburn related to acid reflux. Guidance often recommends taking the medication before a meal to maximize the effect.

Q: Are there long-term studies on the use of Omeprazol Pensa in the elderly?

Official labeling confirms that studies have been performed to assess the drug's profile in the elderly population. These studies have not demonstrated geriatric-specific problems that would limit its usefulness.

Q: Is it possible to take too much Omeprazol Pensa?

Cases of omeprazole overdose have been reported, with the associated symptoms typically described as transient and with no serious outcomes documented in regulatory texts. Treatment, if required, is symptomatic.

Q: Can Omeprazol Pensa be used for a persistent cough related to acid reflux?

Omeprazole is studied in the context of treating conditions like extraesophageal GERD, which may be a suspected factor in a persistent cough. Cough has also been reported as an uncommon adverse reaction to omeprazole.

Q: Is it common to experience dry mouth while using Omeprazol Pensa?

Dry mouth has been reported in scientific literature as an adverse event associated with omeprazole use. However, it is not consistently listed as a common side effect in regulatory documents, which tend to focus on symptoms like headache, nausea, and diarrhea.

Q: What does 'esophagitis' mean in the context of Omeprazol Pensa use?

Esophagitis, such as Erosive Esophagitis (EE), is a medical condition characterized by inflammation or injury to the lining of the esophagus. The esophagus is the tube connecting the throat to the stomach. Omeprazol Pensa is approved to treat this condition by reducing stomach acid.

Advertisements

How should Omeprazol Pensa be stored and disposed of?

How to Store and Dispose of Omeprazol Pensa

The storage and disposal of Omeprazol Pensa must adhere strictly to official regulatory requirements to maintain the product's integrity and ensure safety.


Official Storage Conditions

Omeprazol Pensa capsules must be stored at a temperature below 30 C. The medicine must be kept in its original container and maintained tightly closed to provide protection from moisture.

Safety and Disposal Requirements

It is mandatory to store the medicine out of the sight and reach of children.

Any unused medicinal product or waste material should be disposed of in strict accordance with local requirements established for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Omeprazol Pensa found in:

A-Z Index: